0.5599
6.68%
-0.0401
After Hours:
.56
0.0001
+0.02%
Tc Biopharm Holdings Plc Adr Stock (TCBP) Latest News
TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks
TC BioPharm denies Nasdaq delisting rumors - Investing.com
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks
TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks
TC BioPharm to begin monkeypox treatment studies - Investing.com
TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle
TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News
Balance Sheet Insights: TC BioPharm (Holdings) plc ADR (TCBP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
TC BioPharm secures European patent for cell therapy - Investing.com India
TC BioPharm Regains Nasdaq Compliance - TipRanks
TC BioPharm meets Nasdaq equity requirement - Investing.com
TC Biopharm Unveils Pre-Funded Share Warrants - TipRanks
TC BioPharm secures $2 million in direct offering - Investing.com
TC Biopharm Announces Warrant Adjustment - TipRanks
TC Biopharm At Risk of Nasdaq Delisting - TipRanks
Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance
Apple Hospitality REIT Inc (APLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
TC BioPharm adjusts ADS to ordinary share ratio - Investing.com
TC BioPharm Shareholders Approve Key Resolutions - TipRanks
Is TC BioPharm (Holdings) plc ADR (TCBP) worth investing in despite its overvalued state? – US Post News - US Post News
TC BioPharm Reschedules 2024 AGM for July - TipRanks
TC Biopharm Board Members Resign Suddenly - TipRanks
A year in review: TC BioPharm (Holdings) plc ADR (TCBP)'s performance in the last year – US Post News - US Post News
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer - The Globe and Mail
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - The Globe and Mail
TC Biopharm Announces Corporate Restructuring, Reduction in Overhead - The Globe and Mail
TC BioPharm secures $3.1 million from warrant exercise By Investing.com - Investing.com
Amkor Technology stock rated overweight by JPMorgan, sees strong packaging demand By Investing.com - Investing.com
TC BioPharm eyes expansion with CAR-NK technology LOI - Investing.com
TC BioPharm aims to slash cancer treatment costs By Investing.com - Investing.com
Healthcare Stocks Making Moves Thursday: TCBP, DRRX, CLSD, XRTX, SPRB, IMRX, FWBI, RNXT - InvestorsObserver
symbol__ Stock Quote Price and Forecast - CNN
Healthcare Stocks Making Moves Monday: TCBP, BIAF, LXRX, GRPH, LTRN, OCEA, VTYX, SKYE - InvestorsObserver
TC BioPharm gains MHRA nod for trial amendment By Investing.com - Investing.com
TC Biopharm Plans Share Issuance, Calls Shareholder MeetingTipRanks.com - TipRanks
Healthcare Stocks Moving Up and Down Monday: RNLX, TTOO, CBAY, TLPH, ANTX, TCBP, IVVD, BDSX - InvestorsObserver
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):